DETRALEX PILLS 1000MG
DETRALEX PILLS 1000MG - 30 tabs
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Side effects of the drug Detralex ®,observed during clinical studies were mild. Disturbances from a gastrointestinal tract (diarrhea, dyspepsia, nausea, vomiting) were mainly noted.
While taking the drug Detralex® The following side effects were reported as the following: very often (≥1 / 10), often (≥1 / 100, <1/10), infrequently (≥1 / 1000, <1/100), rarely (≥1 / 10,000, <1/1000), very rarely (<10,000), unspecified frequency (frequency cannot be calculated from available data).
From the side of the central nervous system: rarely - dizziness, headache, general malaise.
From the digestive tract: often - diarrhea, dyspepsia, nausea, vomiting; infrequently - colitis; unspecified frequency - abdominal pain.
From the skin: rarely - rash, itching, urticaria; unspecified frequency - isolated swelling of the face, lips, eyelids; in exceptional cases, angioedema.
The patient should be informed that if any appears during the therapy, including Not mentioned in the instructions, adverse reactions and sensations, as well as changes in laboratory parameters, should be reported to the doctor.
- Hypersensitivity to the active ingredients or excipients that make up the drug.
The use of the drug is not recommended for lactating women.
Use during pregnancy and lactation
Animal experiments revealed no teratogenic effects.
To date, there have been no reports of adverse effects in the use of the drug in pregnant women.
Due to the lack of data regarding the release of the drug in breast milk, nursing women are not recommended to take the drug.
Reproductive toxicity studies showed no effect on reproductive function in rats of both sexes.
Before starting the use of the drug Detralex® the patient is advised to consult a doctor.
With exacerbation of hemorrhoids, the use of the drug Detralex® does not replace the specific treatment of other anal disorders. The duration of treatment should not exceed the time specified in the section "Dosage regimen". In the event that the symptoms do not disappear after the recommended course of therapy, an examination should be carried out by a proctologist who will select further therapy.
In the presence of disorders of the venous circulation, the maximum effect of treatment is provided by a combination of therapy with a healthy (balanced) lifestyle: it is advisable to avoid long exposure to the sun, prolonged standing, and it is recommended to reduce overweight. Walking and, in some cases, wearing special stockings helps to improve blood circulation.
The patient should immediately consult a doctor if the condition worsened or there was no improvement in the treatment process.
Influence on ability to drive motor transport and control mechanisms
The drug does not affect the ability to drive vehicles and perform work that requires a high speed of mental and physical reactions.
Cases of overdose are not described.
In case of overdose, the patient should immediately seek medical attention.
Drug interaction drug Detralex® not noted.
The attending physician should be informed about all medications taken by the patient.
The drug should be stored out of reach of children at a temperature not exceeding 30 ° C. Special storage conditions are not required. Shelf life - 3 years.
Do not use after the expiration date printed on the package.
The drug is approved for use as a means of OTC.